Abstract
We attempted to assess whether microalbuminuria conferred the same cardiovascular risk as overt CVD in type 2 diabetic patients. A prospective cohort study including 436 type 2 diabetic patients (64.8+/-9.2 years old) without proteinuria, with follow-up until any cardiovascular event occurred, was performed. Patients were classified into four groups: group 0, non baseline CVD and normoalbuminuria; group 1, non baseline CVD and microalbuminuria; group 2, baseline CVD and normoalbuminuria; group 3, baseline CVD and microalbuminuria. Cox's multivariate regression models were used to assess the risk ratio (RR) associated with each variable. The median follow-up time was 7.6 years. Incidence rates of cardiovascular events per 1000 patient-years increased from groups 0 to 3 (23.8, 63.4, 74.1, 85.6; p<0.0001). Multivariate RR for incident CVD in groups 1, 2 and 3 in relation to group 0 were 2.8 (95% confidence interval (CI) 1.7-4.6; p<0.0001), 2.7 (95% CI 1.6-4.6; p<0.0001) and 2.9 (95% CI 1.6-5.4; p=0.001), respectively. No significant differences were seen between groups 1 and 2. We suggest that patients with microalbuminuria are at very high vascular risk and should share the same objectives of a vascular risk-factor control as pat...Continue Reading
References
Sep 1, 1991·Diabetologia·M A GallP Hougaard
Oct 1, 1993·Diabetologia·N de F OlivariusC E Mogensen
Jul 14, 1997·Archives of Internal Medicine·S F Dinneen, H C Gerstein
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jul 31, 2001·JAMA : the Journal of the American Medical Association·H C GersteinUNKNOWN HOPE Study Investigators
Aug 4, 2001·Archives of Internal Medicine·F B HuJ E Manson
Aug 21, 2001·Journal of Insurance Medicine·K Petersen
Sep 22, 2001·The New England Journal of Medicine·H H ParvingUNKNOWN Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group
Nov 29, 2001·Clinical Science·R J StevensUNKNOWN United Kingdom Prospective Diabetes Study (UKPDS) Group
Mar 28, 2002·Diabetes·Coen D A StehouwerHans-Henrik Parving
Jul 10, 2002·Stroke; a Journal of Cerebral Circulation·Viti KothariRudy R Holman
Jul 1, 2004·Circulation·Sidney C SmithScott M Grundy
Aug 25, 2004·Lancet·Helen M ColhounUNKNOWN CARDS investigators
Sep 11, 2004·Journal of the American College of Cardiology·Scott M GrundyUNKNOWN Coordinating Committee of the National Cholesterol Education Program
Dec 21, 2004·Diabetic Medicine : a Journal of the British Diabetic Association·J A Gimeno-OrnaM A Sancho-Serrano
Dec 25, 2004·Diabetes Care·UNKNOWN American Diabetes Association
Apr 12, 2005·Current Opinion in Nephrology and Hypertension·Matthew F YuyunNicholas J Wareham
Jun 29, 2005·Diabetes Care·Lucinda WhiteleyChris Isles
Citations
Feb 15, 2011·International Journal of Clinical Practice·M Mata-CasesM I Fernández-Sanmartín
Jan 19, 2010·Cardiovascular Diabetology·Martin MagnussonOlle Melander
Feb 20, 2007·The American Journal of Cardiology·LaDale St Clair, Christie M Ballantyne
Jun 2, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·C L BlacklockA J Farmer
Mar 12, 2010·Diabetes/metabolism Research and Reviews·Agnès MathesonBradley J Walsh
Feb 15, 2008·Diabetes Care·Seema BasiJulia B Lewis
Oct 12, 2010·Acta Biochimica Et Biophysica Sinica·Ting LaiMingrong Xi
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity